Woods, Christopher W., Ana M. Sanchez, Geeta K. Swamy, Micah T. McClain, Lynn Harrington, Debra Freeman, Elizabeth A. Poore, et al. “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults..” Vaccine 37, no. 30 (July 9, 2019): 4222–30. https://doi.org/10.1016/j.vaccine.2018.12.026.
Geeta Krishna Swamy, MD
Associate Professor of Obstetrics and Gynecology
Campus Mail:
Box 3967 Med Ctr, Durham, NC 27710
Phone:
(919) 681-5220
Email:
swamy002@mc.duke.edu
Dr. Geeta Swamy, MD, became Vice Chair for Research and Faculty Development in the Department of Obstetrics and Gynecology on March 1, 2018. In this dual role, Dr. Swamy oversees strategic development and administration of the Department’s basic, translational and clinical research programs, as well as implements and oversees programs to support development and mentorship for all faculty at all levels.
Dr. Swamy has dedicated her career to advancing research in women’s health and to mentoring faculty and trainees. She is an internationally recognized clinician-researcher, and an expert and nationally-recognized leader in the field of maternal immunization and vaccination in pregnancy. Her research has been funded by the National Institutes of Health (NIH), Centers for Disease Control (CDC), Environmental Protection Agency (EPA) and others. She currently serves as the Co-Principal Investigator for the NIH-NIAID Vaccine Treatment and Evaluation (VTEU) and CDC-funded Clinical Immunization Safety Assessment, and has published over 100 peer-reviewed manuscripts. Dr. Swamy has been the Director of the Duke Perinatal Research Center since 2010.
Dr. Swamy has also been instrumental in developing and leading the School of Medicine’s Research Regulatory and Compliance initiatives, first as Chair of the IRB and then as Associate Dean for Clinical Research for Regulatory Oversight and Research Initiatives. This past fall, she was promoted to Senior Associate Dean for Clinical Research in the School of Medicine.
Dr. Swamy's focused area of interests are perinatal infection, maternal immunization and preterm birth.
Education and Training
- Resident, Obstetrics And Gynecology, University of Pittsburgh, 1997 - 2001
- M.D., University of North Carolina at Chapel Hill, 1997
Selected Grants and Awards
- Population Health Research Support IDIQ Base
- VTEU A-1 Admin
- Duke CTSA (KL2)
- Duke CTSA (TL1)
- CISA 2018-2019- Clinical Consult - Opt 1
- RTOP 2018 CISA 01 Flublok Lead Base
- RTOP 2018 CISA 01 Flublok Lead Task 1
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study Capitation
- VTEU Task Order 18-0011.B1.C1.0116-Task C Option 1
- NICHD Maternal Fetal Medicine Units Network
- Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
- RSV- M-301
- The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
- VTEU Task Area C Option 2-3 Protocol 15-0020.B1C1.0040
- VTEU Task Area C Option 2-2 Protocol 15-0020.B1C1.0040
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
- Rapid, Near Patient Nucleic Acid Testing for Infant Cytomegalovirus (CMV) Infection
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- MFMU Network Studies
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
- Duke Research Training Program for Pediatricians
- Duke CTSA (UL1)
- RSV-M-203
- CISA Task Order No. 3 Tdap Safety in Pregnant Women
- V98_12
- DMID 05-0048 Tdap Vaccine in Pregnant Women
- DMID 09-0005 Safety and Immunogenicity
- Effectiveness of a Vaccination Program in the Community ObGyn Setting
- 09-0056 A Phase II Study in Pregnant Women to Assess H1N1 Vaccine
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant
- PiiiTCH Study
Publications
Swamy, Geeta K., and Sarah K. Dotters-Katz. “Safety and varicella outcomes after varicella zoster immune globulin administration in pregnancy..” Am J Obstet Gynecol, July 4, 2019. https://doi.org/10.1016/j.ajog.2019.07.003.
Simon, Christian, Rebecca W. Beerman, Jennifer L. Ariansen, Donna Kessler, Ana M. Sanchez, Kindra King, Marcella Sarzotti-Kelsoe, et al. “Implementation of a responsible conduct of research education program at Duke University School of Medicine..” Account Res 26, no. 5 (July 2019): 288–310. https://doi.org/10.1080/08989621.2019.1621755.
Wheeler, Sarahn, Anna DeNoble, Clara Wynn, Kristin Weaver, Geeta Swamy, Mark Janko, and Paul Lantos. “Beyond the Window: Patient Characteristics and Geographic Locations Associated with Late Prenatal Care in Women Eligible for 17-P Preterm Birth Prevention..” J Racial Ethn Health Disparities 6, no. 3 (June 2019): 563–69. https://doi.org/10.1007/s40615-018-00555-8.
Harris, Benjamin S., Maeve K. Hopkins, Margaret S. Villers, Jeremy M. Weber, Carl Pieper, Chad A. Grotegut, Geeta K. Swamy, Brenna L. Hughes, and R Phillips Heine. “Efficacy of Non-Beta-lactam Antibiotics for Prevention of Cesarean Delivery Surgical Site Infections..” Ajp Rep 9, no. 2 (April 2019): e167–71. https://doi.org/10.1055/s-0039-1685503.
Gyamfi-Bannerman, Cynthia, John A. F. Zupancic, Grecio Sandoval, William A. Grobman, Sean C. Blackwell, Alan T. N. Tita, Uma M. Reddy, et al. “Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial..” Jama Pediatr, March 11, 2019. https://doi.org/10.1001/jamapediatrics.2019.0032.
Hopkins, Maeve K., Chad A. Grotegut, Geeta K. Swamy, Evan R. Myers, and Laura J. Havrilesky. “Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis..” Am J Perinatol 36, no. 4 (March 2019): 399–405. https://doi.org/10.1055/s-0038-1668591.
Healy, Sara A., Michal Fried, Thomas Richie, Karin Bok, Maggie Little, Allison August, Laura Riley, et al. “Malaria vaccine trials in pregnant women: An imperative without precedent..” Vaccine 37, no. 6 (February 4, 2019): 763–70. https://doi.org/10.1016/j.vaccine.2018.12.025.
Werner, Erika F., Megan E. Romano, Dwight J. Rouse, Grecio Sandoval, Cynthia Gyamfi-Bannerman, Sean C. Blackwell, Alan T. N. Tita, et al. “Association of Gestational Diabetes Mellitus With Neonatal Respiratory Morbidity..” Obstet Gynecol 133, no. 2 (February 2019): 349–53. https://doi.org/10.1097/AOG.0000000000003053.
DeNoble, Anna E., Clara E. Wynn, Kristin E. Weaver, Sarahn M. Wheeler, and Geeta K. Swamy. “Factors Associated with Utilization of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth..” Am J Perinatol, February 1, 2019. https://doi.org/10.1055/s-0039-1678532.